VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | An update on camidanlumab tesirine in HL

In this video, Alex Herrera, MD, City of Hope, Duarte, CA, shares some updates from a Phase II study evaluating the use of camidanlumab tesirine in patients with relapsed/refractory (R/R) Hodgkin lymphoma (HL). This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter